FDA Approves First New Molecular Entity Under National Priority Voucher Program
FDA Approves First New Molecular Entity Under National Priority Voucher Program
http://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
Aphreseller (Buy-herbal.com) Issues Voluntary Nationwide Recall of Kian Pee Wan Capsules Due the Presence of Undeclared Dexamethasone and Cyproheptadine
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-severe-leukocyte-adhesion-deficiency-type-i
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
http://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-neurologic-manifestations-hunter-syndrome
Cryoprobe Recall: Erbe USA Removes Flexible Cryoprobes
Heating Pad Recall: Navajo Manufacturing Company Removes Handy Solutions Neck & Shoulders Heating Pad
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
FDA Schedules Public Meeting on the Commissioner’s National Priority Voucher Pilot Program
http://www.fda.gov/news-events/press-announcements/fda-schedules-public-meeting-commissioners-national-priority-voucher-pilot-program